Funding
1,740 funding - 186,561,364€
2024
-
Actividades CRO TranspoCART
-
Development of new generation Tc-99m kits
-
RNA-based cancer ImmunotheraPeutics to Enhance CROssPrimming
euro 2,411,500.00
-
SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment
euro 619,650.00
-
SPACETIME
-
I+D hormigón
-
Pruebas PET Amiloide y PET Tau
euro 24,600.00
-
FOXO as a central axis in DMG response to therapy.
euro 61,020.00
-
Desarrollo de células CAR-T de cuarta generación (TRUCKs) mu
-
Estudio experimental del ácido hidroxicítrico (FagolitosPlus
-
Rational to modulate the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)
euro 42,162.00
-
Subproductos de alcachofa como fuente de ácidos hidroxicinámicos: descifrando su potencial en prevención de diabetes mediante estrategias de reciclaje y enfoque multi-ómico. (ARTI-UP).
-
Bridge MDACC-FIMA-CUN
-
Diverging HFpEF Phenotypes : patient-tailoreD targeting of anti-Inflammatory pathways to limit Ventricular and Atrial remodelling
euro 198,750.00
-
ACUERDO SHARE
-
Role of amino acid metabolism reprogramming and calpain deregulation in fibroblasts activation and diffuse myocardial fibrosis in heart failure
euro 150,000.00
-
Propósito personal
euro 35,000.00
-
Financial Contribution for Project Management Support
euro 214,326.00
-
Competición entre escalas temporales en flujos con interés biológico
euro 82,500.00
-
Diseño y desarrollo de una vacuna frente a Leishmaniosis
euro 400,000.00